Norgesterone

This classification denotes a therapeutic progestin with the molecular formula C20H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YFS274763Y, chemically known as 19-norpregna-5(10),20-dien-3-one, 17-hydroxy-, (17alpha)- (9ci) but generally known as norgesterone, which bears US NIH Compound Identifier 65606. European Medicines Agency schedules Norgesterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09368MIG. The term NORGESTERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). NORGESTERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule norgesterone under HS 29372300 and SITC 54153. As of Q4 2014, NORGESTERONE remains the US FDA Preferred Term for this commodity. Norgesterone bears US NLM identifiers UMLS ID C0603673 and NCI Concept Code C90971. SMILES: OC1(C2(C(C3C(CC2)C2=C(CC3)CC(=O)CC2)CC1)C)C=C.